Status:
RECRUITING
Conservative Management of Left Ventricular Assist Device Candidates
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Advanced Heart Failure
Eligibility:
All Genders
18-80 years
Brief Summary
Left ventricular assist device (LVAD) candidates will be comprehensively evaluated at our center, including clinical evaluation, echocardiography, right heart catheterization, cardiopulmonary exercise...
Detailed Description
Consecutive patients with advanced heart failure (HF) who will be referred for LVAD implantation starting 01/2018. All patients will have severe left ventricular systolic dysfunction (left ventricular...
Eligibility Criteria
Inclusion
- \- left ventricular ejection fraction \<35%. New York Heart Association Class III or IV. Brain natriuretic peptide levels \> 450pg/ml. Heart failure hospitalization in the past 6 months. Maximal oxygen consumption \< 12 ml/kg/min. Intolerant to conventional heart failure therapy.
Exclusion
- \- Special populations - pregnant, unable to give informed consent. Advanced liver disease (Child Pugh class B or C). Advanced kidney disease (eGFR\<30ml/min). Severe pulmonary disease. Severe peripheral vascular disease. Active malignancy.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05271214
Start Date
January 1 2018
End Date
January 1 2028
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, 6423906